EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)

CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia

Ruonan Li, Hong Pan, Lele Zhang iD, Jiaxiu Ma, Weiwang Li, Zhen Gao, Liwei Fang, Linzhu Tian, Yucan Shen, Fei Yang, Jingyu Zhao, Neng Nie und 26 weitere

New England Journal of Medicine · 15.01.2026 · 394 (3) · 253-267

DOI: 10.1056/nejmoa2509820 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, erschienen am 15.01.2026. Verfasst von Ruonan Li und 37 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, Antigens, CD19, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: State Key Laboratory of Experimental Hematology, Chinese Academy of Medical Sciences, Natural Science Foundation of Tianjin City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Hemolytic, AutoimmuneAntigens, CD19Immunotherapy, AdoptiveReceptors, Chimeric AntigenAdultFemaleHumansMaleMiddle AgedYoung AdultB-LymphocytesCytokine Release SyndromeRecurrenceFollow-Up StudiesNeurotoxicity SyndromesChildTreatment Outcome

Substanzen

Antigens, CD19Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical…
  • Tianjin Institutes of Health Science, Tianjin, China.
  • Red Blood Cell Diseases Center and Regenerative Medicine Clinic, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
  • Juventas Cell Therapy, Tianjin, China.
  • Engineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai.

ORCID-Profile: Lele Zhang

Förderung

  • State Key Laboratory of Experimental Hematology
  • Chinese Academy of Medical Sciences
  • Natural Science Foundation of Tianjin City
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • State Key Laboratory of Experimental Hematology Research Grant
  • Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • Natural Science Foundation of Tianjin

Zitieren

APA

Li, R., Pan, H., Zhang, L., Ma, J., Li, W., Gao, Z., Fang, L., Tian, L., Shen, Y., Yang, F., Zhao, J., Nie, N., Li, J., Wang, W., Pan, X., Lian, Y., Li, X., Peng, G., Li, L., …, & Shi, J. (2026). CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia. New England Journal of Medicine, 394(3), 253-267. https://doi.org/10.1056/nejmoa2509820

Vancouver

Li R, Pan H, Zhang L, Ma J, Li W, Gao Z, et al. CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia. New England Journal of Medicine. 2026;394(3):253-267. doi:10.1056/nejmoa2509820

BibTeX
@article{Li2026,
  author = {Li, Ruonan and Pan, Hong and Zhang, Lele and Ma, Jiaxiu and Li, Weiwang and Gao, Zhen and Fang, Liwei and Tian, Linzhu and Shen, Yucan and Yang, Fei and Zhao, Jingyu and Nie, Neng and Li, Jianping and Wang, Wenyan and Pan, Xinan and Lian, Yu and Li, Xingxin and Peng, Guangxin and Li, Liyun and Yu, Xiao and Xu, Chun and Liu, Yanjie and Kuang, Zhexiang and Huang, Jinbo and Zhao, Xin and Ge, Meili and Liu, Lijun and Chen, Shuo and Feng, Yi and Chang, Alex H and Deng, Biping and Dai, Min and Huang, Lifang and Lv, Lulu and Zheng, Yizhou and Luo, Yuechen and Xiong, Haiqing and Shi, Jun},
  title = {CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {3},
  pages = {253--267},
  doi = {10.1056/nejmoa2509820}
}
Kostenlos starten →